BRC Therapeutics participates in regulators' workshop advancing botanical drug development

Lupin announces receipt of US FDA tentative approval for Apixaban Oral Suspension

QIAGEN completes US QIAstat-Dx bloodstream infection portfolio with FDA clearance

Innovent expands global Phase 3 study of IBI363/TAK-928 to include non-squamous NSCLC

FDA approves WELIREG and LENVIMA combination for previously treated advanced renal cell carcinoma

AstraZeneca's IMFINZI combination receives US Priority Review for muscle-invasive bladder cancer

XtalPi submits US FDA IND application for KQTD-126 in chronic intestinal pain

Revvity launches IVDR-certified solution for early detection of type 1 diabetes

FDA Advisory Committee votes in favour of GRAIL's Galleri multi-cancer early detection test

AstraZeneca's Trixeo Aerosphere approved in EU for asthma maintenance treatment

AbbVie secures EU approval for RINVOQ in polyarticular juvenile idiopathic arthritis

Clene Inc closes registered direct offering of common stock to existing shareholders

Beacon Therapeutics reports positive topline results from VISTA trial in X-linked retinitis pigmentosa

Insmed's ARIKAYCE sNDA granted priority review by FDA

Precigen announces FDA platform technology designation for AdenoVerse